Literature DB >> 34346208

Incorporation of Layered Rectorite into Biocompatible Core-Sheath Nanofibrous Mats for Sustained Drug Delivery.

Hu Tu1,2, Fangfang Dai3, Gu Cheng4, Mengqin Yuan3, Xue Zhou5, Yanqing Wang3, Ruquan Zhang2, Yajing Zheng3, Yanxiang Cheng3, Hongbing Deng1.   

Abstract

Searching for drug carries with controlled release and good biocompatibility has always been one of the research hotspots and difficulties. Herein, core-sheath nanofibrous mats (NFs) consisting of biocompatible poly(ethylene oxide) (PEO, core) and poly(l-lactic acid) (PLLA, sheath) for drug delivery were fabricated via coaxial electrospinning strategy. The nontoxic layered silicate rectorite (REC) with 0.5-1 wt % amount was introduced in the sheath for sustained drug delivery. Layered REC could be intercalated with PLLA macromolecule chains, leading to the densified structure for loading and keeping doxorubicin hydrochloride (DOX) while reversibly capturing and releasing DOX to delay the drug migration due to its high cation activity. The addition of REC in NFs could delay the initial burst release of DOX and prolong the residence time from 12 to 96 h. Moreover, DOX-loaded core-sheath NFs had in vitro culture with strong antitumor activity, which was confirmed by cytotoxicity results and live and dead assay. HepG2 tumor-bearing xenograft further demonstrated the tumor-suppression effect and the excellent safety of the DOX-loaded core-sheath NFs in vivo. The constructed NFs as drug carriers showed great potential in the local treatment of solid tumors.

Entities:  

Keywords:  antitumor effects; coaxial electrospinning; controlled release; drug delivery; rectorite

Year:  2021        PMID: 34346208     DOI: 10.1021/acsbiomaterials.1c00638

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  1 in total

1.  Electrospun Cellulose-Acetate/Chitosan Fibers for Humic-Acid Removal: Improved Efficiency and Robustness with a Core-Sheath Design.

Authors:  Yirong Zhang; Yixiang Wang
Journal:  Nanomaterials (Basel)       Date:  2022-04-09       Impact factor: 5.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.